Literature DB >> 23886819

Investigating herb-drug interactions: the effect of Citrus aurantium fruit extract on the pharmacokinetics of amiodarone in rats.

Márcio Rodrigues1, Gilberto Alves, Amílcar Falcão.   

Abstract

Citrus aurantium extract has been largely used in weight loss and sports performance dietary supplements. However, the safety of C. aurantium-containing products has been questioned mainly due to the association of its use with adverse events in the cardiovascular system. Therefore, this work aimed to assess the potential for herb-drug interactions among a standardized C. aurantium extract (GMP certificate) and amiodarone (narrow therapeutic index drug) in rats. In a first pharmacokinetic study, rats were simultaneously co-administered with a single-dose of C. aurantium (164 mg/kg, p.o.) and amiodarone (50 mg/kg, p.o.); in a second study, rats were pre-treated during 14 days with C. aurantium (164 mg/kg/day, p.o.) and received amiodarone (50 mg/kg, p.o.) on the 15th day. Rats of the control groups received the corresponding volume of vehicle. Overall, after analysis of the pharmacokinetic data, it deserves to be highlighted the significant increase of the peak plasma concentration of amiodarone in rats pre-treated with C. aurantium extract, while the extent of systemic exposure was comparable between both groups. This paper reports, for the first time, data on the potential of herb-drug interaction between C. aurantium extract and amiodarone. However, specific clinical trials should be performed to confirm these results in humans.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AM; AUC; AUC from time zero to infinite; AUC from time zero to the last sampling time; AUC(0−)(t); AUC(0−∞); Amiodarone; C(last); C(max); CYP; Citrus aurantium; FDA; Food and Drug Administration; Herb–drug interaction; LOQ; MDEA; MRT; P-glycoprotein; P-gp; Pharmacokinetics; Rats; SD; UV; amiodarone; apparent terminal elimination half-life; apparent terminal rate constant; area under the concentration-time curve; cytochrome P450; i.p.; intraperitoneal; k(el); last quantifiable concentration; limit of quantification; mean residence time; mono-N-desethylamiodarone; peak concentration; standard deviation; t(1/2el); t(max); time to reach C(max); ultraviolet detection

Mesh:

Substances:

Year:  2013        PMID: 23886819     DOI: 10.1016/j.fct.2013.07.041

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  5 in total

1.  Effects of Lemon and Seville Orange Juices on the Pharmacokinetic Properties of Sildenafil in Healthy Subjects.

Authors:  Khaled S Abdelkawy; Ahmed M Donia; R Brigg Turner; Fawzy Elbarbry
Journal:  Drugs R D       Date:  2016-09

Review 2.  An Overview on Citrus aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent.

Authors:  Ipek Suntar; Haroon Khan; Seema Patel; Rita Celano; Luca Rastrelli
Journal:  Oxid Med Cell Longev       Date:  2018-05-02       Impact factor: 6.543

Review 3.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

4.  Citrus aurantium L. and Its Flavonoids Regulate TNBS-Induced Inflammatory Bowel Disease through Anti-Inflammation and Suppressing Isolated Jejunum Contraction.

Authors:  Wei He; Yongmin Li; Mengyang Liu; Haiyang Yu; Qian Chen; Yue Chen; Jingya Ruan; Zhijuan Ding; Yi Zhang; Tao Wang
Journal:  Int J Mol Sci       Date:  2018-10-07       Impact factor: 5.923

5.  Interaction of p-synephrine on the pharmacodynamics and pharmacokinetics of gliclazide in animal models.

Authors:  Leela Krishna Vatsavai; Eswar Kumar Kilari
Journal:  J Ayurveda Integr Med       Date:  2017-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.